Main Menu
X-twitter Linkedin-in

News

Industry news, press releases, and official statements from USIJ.
New Study Shows Large Patent Damages Rarely Survive Intact on Appeal
  • Industry News
USIJ One-Pagers: Why MFN Drug Pricing Fails — and Better Alternatives
  • Industry News
USIJ Files Amicus Brief Supporting Dolby Laboratories
  • Amicus Briefs
USIJ Urges Lawmakers to Reject ETHIC Act, Protect Patent Rights
  • Industry News
USIJ Executive Director Chris Israel Warns Against Importing Foreign Price Controls
  • Industry News
USIJ Hosts Virtual Roundtable With Fmr. Deputy USTR Jeff Gerrish
  • Industry News
USIJ Files Amicus Brief Defending USPTO Discretion and Inventor Protections
  • Amicus Briefs
New USIJ White Paper Examines Public Opposition to MFN Drug Pricing Policy
  • Industry News
USIJ Opposes CMS Proposal That Undermines Patents for Reformulated Medicines
  • Comments & Letters
USIJ Urges Action to End Foreign Free-Riding on American Innovation
  • Comments & Letters

Sign up to receive news and updates from USIJ.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Scroll to Top